TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The investigators performed a multicenter, open trial of using TS gene polymorphism to
predict advanced lung adenocarcinoma effect to pemetrexed combined with cisplatin regiment as
first-line treatment.